Chemoinformaics analysis of Heneicosane 11-(1-ethylpropyl)
| Molecular Weight | 366.718 | nRot | 21 |
| Heavy Atom Molecular Weight | 312.286 | nRig | 0 |
| Exact Molecular Weight | 366.423 | nRing | 0 |
| Solubility: LogS | -7.858 | nHRing | 0 |
| Solubility: LogP | 11.72 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 80 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 54 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 26 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 79.4268 |
| nHD | 0 | BPOL | 54.1732 |
| QED | 0.177 |
| Synth | 1.995 |
| Natural Product Likeliness | 0.492 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.002 |
| CACO-2 | -5.042 |
| MDCK | 0.00000449 |
| BBB | 0.004 |
| PPB | 0.987718 |
| VDSS | 4.551 |
| FU | 0.00710526 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.172 |
| CYP2c19-inh | 0.174 |
| CYP2c19-sub | 0.071 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.95 |
| CYP2d6-inh | 0.104 |
| CYP2d6-sub | 0.024 |
| CYP3a4-inh | 0.222 |
| CYP3a4-sub | 0.059 |
| CL | 4.615 |
| T12 | 0.009 |
| hERG | 0.392 |
| Ames | 0.003 |
| ROA | 0.027 |
| SkinSen | 0.942 |
| Carcinogencity | 0.012 |
| EI | 0.933 |
| Respiratory | 0.048 |
| NR-Aromatase | 0.076 |
| Antiviral | Yes |
| Prediction | 0.642221 |